(Q42684061)

4 November 2017

title

Improved survival among sickle cell kidney transplant recipients in the recent era. (English)

1 reference

4 November 2017

0 references

Edmund Huang

1

1 reference

4 November 2017

Chong Parke

2

1 reference

4 November 2017

Alireza Mehrnia

3

1 reference

4 November 2017

Mandana Kamgar

4

1 reference

4 November 2017

Phuong-Thu Pham

5

1 reference

4 November 2017

Gabriel Danovitch

6

1 reference

4 November 2017

Suphamai Bunnapradist

7

1 reference

4 November 2017

language of work or name

English

0 references

publication date

22 January 2013

1 reference

Nephrology Dialysis Transplantation

4 November 2017

published in

1 reference

4 November 2017

volume

28

1 reference

4 November 2017

issue

4

1 reference

4 November 2017

page(s)

1039-1046

1 reference

Pathogenesis and treatment of sickle cell disease

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Renal abnormalities in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Renal transplantation in end-stage sickle cell nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Relationship between underlying renal disease and renal transplantation outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Patient survival after renal transplantation; more than 25 years follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Circumstances of death in adult sickle cell disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Causes of death in sickle cell disease: an autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Glomerular lesions in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFS585

21 January 2018

Identifiers

DOI

10.1093/NDT/GFS585

1 reference

4 November 2017

1 reference